ABSTRACT Cardiac electrophysiologic effects of verapamil in vivo are the result of both direct and indirect actions on the heart (the latter due to augmentation of sympathetic neural tone, diminution of parasympathetic neural tone, and increased circulating catecholamines). In this study we assessed the interaction of verapamil's direct and indirect actions on electrophysiologic properties of the heart in awake, previously instrumented, unsedated dogs. After administration of intravenous verapamil (0.2 mg/kg), electrophysiologic effects were assessed serially over a
CARDIAC ELECTROPHYSIOLOGIC effects of verapamil in vivo are the result of both direct electrophysiologic actions on the heart and indirect responses mediated by neural mechanisms and alterations in circulating catecholamines. Verapamil's principal direct cardiac electrophysiologic effects include slowing of heart rate and prolongatlon of atrioventricular node conduction times and refractory periods, actions that are primarily attributable to "slow inward current" blockade. '-3 In addition, as a consequence of slow inward current blockade, verapamil interferes with excitation-contraction coupling in vascular tissue, resulting in a reduction in vascular smooth muscle tone. The latter effect, particularly after parenteral administration of verapamil, has been associated with develop-ment of transient systemic hypotension 6 and initiation of secondary compensatory increases in sympathetic neural trafflc and circulating catecholamines that tend to oppose the direct electrophysiologic effects of the drug.
This study was designed to assess the interaction of verapamil's direct and indirect effects on the magnitude and time course of the drug's cardiac electrophysiologic actions in vivo. To this end, serial electrophysiologic measurements were obtained before and for a 1 hr period after parenteral administration of verapamil in previously instrumented unsedated dogs under control conditions, after pharmacologic autonomic blockade, and after orthotopic cardiac transplantation.
Methods
Instrumentation. Adult mongrel dogs weighing from 18 to 25 kg (mean 21) were instrumented with epicardial bipolar electrodes suitable for performing serial electrophysiologic evaluation of sinus and atrioventricular nodal function ( figure   1 ).' Long-term implantation of intravascular catheters to permit monitoring of intra-arterial pressure was attempted during the development of this animal preparation, but was abandoned due HBE Svc RA(P) LV(S) LV(P)V(S FIGURE 1. Illustration depicting the instrumentation used in these studies. Pairs of epicardial bipolar electrodes for sensing (S) and pacing (P) were sutured to the right atrium (RA), right ventricle (RV), and left ventricle (LV). An epicardial His bundle electrode (HBE) was also implanted adjacent to noncoronary sinus of Valsalva. Site of HBE implantation was determined via intraoperative His bundle mapping. SVC = superior vena cava; AO = aorta; PA -pulmonary artery; LA = left atrium.
to a high incidence of associated infectious complications, particularly among immunosuppressed animals. Short-term insertion of catheters in unsedated awake animals was believed to be undesirable, since restraints and immobilization would have been necessary. All animals were allowed 2 weeks to recover from surgery, and were conditioned to lie quietly in an unsedated state for electrophysiologic studies.
Experimental protocol Studies in unsedated dogs (group 1 studies). Instrumented animals (n= 10) underwent electrophysiologic assessment of sinus and atrioventricular node function before and at 5, 10, 15, 30, and 60 min after the administration of verapamil (0.2 mg/kg) by rapid intravenous injection.
Studies after pharmacologic autonomic blockade (group 2 studies). After initial evaluation, all animals underwent a second series of electrophysiologic studies (group 2). Electrophysiologic measurements were obtained as described above for group 1 studies after pharmacologic autonomic blockade was induced by the administration of 2 mg/kg propranolol and 0.05 mg/kg atropine intravenously. To maintain muscarinic blockade, supplemental atropine (0.02 mg/kg) was administered every 15 min throughout the duration of study.
Studies after orthotopic cardiac transplantation (group 3 studies). After completion of group 1 and group 2 studies, instrumented animals were used as cardiac allograft donors for weight-and size-matched cardiac transplant recipients (group 3, n= 5). Animals were allowed 2 weeks to recover from surgery, and were conditioned to lie quietly for electrophysiologic studies. Animals were maintained on immunosuppressive therapy (18 mg/kg cyclosporin; 2 mg/kg prednisone orally) and subjected to transvenous endomyocardial biopsy before electrophysiologic study to rule out the presence of cardiac rejection. Transplant recipients then underwent serial electrophysiologic study before and after administration of verapamil by the same protocol as outlined for group 1 and 2 studies.
Verapamil, 0.2 mg/kg iv, was used in all studies. The drug dose was selected in an attempt to maximize drug effects yet remain within a clinically applicable range (typical reported treatment range in man, 0.1 to 0.2 mg/kg iv).
Electrophysiologic studies. The following electrophysiologic measurements were obtained for each time period (baseline, 5, 10, 15, 30, and 60 min) in each study group Verapamil plasma concentration. The potential effects of either pharmacologically induced autonomic blockade or cardiac transplantation on serum concentrations of verapamil were assessed in a separate series of eight awake unsedated dogs (three control dogs, three dogs after pharmacologic autonomic blockade, and two dogs subjected to orthotopic cardiac transplantation). In each animal blood samples were obtained through an indwelling catheter immediately before and at 5, 10, 15, 30, and 60 min after verapamil (0.2 mg/kg iv). The blood samples were spun immediately and the plasma was frozen. Plasma levels were measured by a high-pressure liquid chromatography technique (Medtox Inc., Minneapolis). Analysis of variance was used to assess statistical significance of changes in serial electrophysiologic measurements after administration of verapamil. Comparison of verapamilinduced electrophysiologic changes among the three study groups was facilitated by normalizing all measurements with respect to the baseline value before administration of verapamil. Student's t test was used to evaluate intergroup differences. Statistical significance was assumed at p < .05. The timing of verapamil's peak effect on AH interval and the duration of AH interval prolongation varied among the three study groups. In group 1 dogs peak effect occurred at 10 min (46% increment over baseline value, p < .02). At 60 min the AH interval remained 14% above baseline value in group 1 dogs. In group 2 dogs, peak AH interval prolongation occurred at 10 min (78% increment from baseline value, p < .01) and the AH interval was still 30% above baseline (p < .01) at 60 min after infusion. In group 3 studies maximum AH interval prolongation occurred within 5 min of drug infusion; there was a gradual diminution of effect thereafter, but the interval remained 13% above baseline at 60 min.
The HV interval was not measurably influenced by verapamil in any of the experimental groups.
Atrioventricular node refractory periods. Administration of verapamil tended to prolong both AVERP and AVFRP in all three study groups (table 1) . In group I studies maximum observed AVERP and AVFRP prolongation was approximately 14% above baseline (p = .27 and .079, respectively), and occurred 30 min after drug administration. For group 2 dogs, maximum AVERP and AVFRP prolongation was 74% and 51%, respectively (p < .001 vs baseline values), and occurred at 5 min after drug. In the group 3 in which we were able to measure AVERP and AVFRP after verapamil, the maximum increments in AVERP and AVFRP were 70% and 40%, respectively, and occurred within 5 min of drug infusion (table 1) . The latter marked prolongation of atrioventricular refractoriness tended to diminish only slowly throughout the duration of the study. For example, at 60 min, the mean values of AVERP and AVFRP remained 30% and 20% above baseline values, respectively. Verapamil plasma concentrations. Table 2 summarizes plasma concentrations of verapamil at 5, 10, 15, 30, and 60 min after administration of drug in a separate series of eight dogs (three controls, three receiving pharmacologic autonomic blockade, and two after cardiac transplantation). Marked interanimal variability in verapamil levels was observed. Nonetheless, peak drug levels were typically observed at 5 min, consistent with the timing of maximum direct electrophysiologic effects. Of note, verapamil levels were not higher in animals receiving pharmacologic blockade or transplants, suggesting that differences in drug levels did not adequately account for the apparent potentiation of effects of verapamil in group 2 and 3 animals. Indeed, while statistical significance cannot be assessed, drug levels in the presence of autonomic blockade or cardiac 5 130 2200 395  40  30  65  45  130  10  70  440 125  35  35  40  40  70  15  75  130  85  30  25  35  25  75  30  80  150  20  35  20  40  35  80  60  90  240  25  15  20  25  20  90 ND = not determined.
transplantation were equal to or less than those in control dogs.
Discussion
This study provides three major observations regarding interaction of the direct and indirect effects of parenterally administered verapamil on electrophysiologic properties of the heart in vivo. First, in the normal awake unsedated dog (group 1) verapamil's negative chronotropic effect was consistently preceded by a transient acceleration of heart rate, a finding that was blunted in the transplanted heart (group 3) and abolished in the presence of pharmacologic autonomic blockade (group 2). Second, although verapamil exerted a negative dromotropic effect on the atrioventricular node in all three experimental groups, this effect was accentuated in the presence of pharmacologic autonomic blockade or in dogs subjected to cardiac transplantation. Finally, the interval between completion of drug infusion and peak verapamil-induced electrophysiologic effect differed depending on experimental conditions. In normal unsedated dogs (group 1) maximum effect usually did not become manifest until 30 min after completion of the infusion of verapamil. In contrast, verapamil's negative chronotropic and dromotropic effects were almost immediate (usually ' 5 min) in the presence of pharmacologic autonomic blockade or after cardiac transplantation (table 1). The differences in the temporal sequence of peak effects of verapamil were not attributable to differences in the timing of peak plasma verapamil levels. It was not feasible to assay verapamil tissue levels during the conduct of studies designed to assess the temporal sequence of drug effects. Consequently, we conclude that verapamil-induced reflex augmentation of sympathetic neural tone and/or diminution of parasympathetic tone (not apparent in group 2 and 3 animals) masked, and to some extent transiently reversed, direct effects of the drug in group 1 (control) dogs.
Effects 23 In the former circumstance, verapamil often interrupts reciprocating tachycardias within 1 to 2 min after infusion, 19 20 while in the treat-ment of atrial fibrillation its peak effects tend to occur later.24 These observations with regard to the temporal course of verapamil's therapeutic effects may in part be explained by our findings. Unlike in the sinus node, verapamil's direct negative dromotropic effects on atrioventricular nodal tissue predominate over its indirect effects. Immediate postinfusion prolongation of AH interval, AVERP, and AVFRP was observed in all three experimental groups. Conceivably even a relatively small negative dromotropic effect occurring early after verapamil administration may be sufficient to interrupt the critical timing of a reentry loop, while the more slowly developing peak drug effect would only become apparent clinically during uninterrupted tachyarrhythmias, such as atrial fibrillation.
In summary, our results support the concept that indirect cardiac electrophysiologic effects resulting from reflex neurohumoral responses induced by parenteral administration of verapamil may transiently overcome the direct electrophysiologic effects of the drug on the sinus node and may attenuate its direct effects on the atrioventricular node in vivo. Circumventing the effects of neural and/or humoral reflex mechanisms either by pharmacologic autonomic blockade or cardiac transplantation permits the direct negative chronotropic and dromotropic effects of verapamil to become more readily apparent. Thus, if verapamil is to be used, it should be administered only with caution to those patients treated concomitantly with adrenergicblocking drugs or individuals who have undergone cardiac transplantation. On the other hand, cautious application of combined /3-adrenergic and slow inward current blockade offers a potentially useful synergistic therapeutic combination for treatment of patients with atrioventricular reentrant or primary atrial tachyarrhythmias. 25, 26 
